Revealing rutaecarpine’s promise: A pathway to parkinson’s disease relief through PPAR modulation
Yeying Wang(Nanchang University), Hong Zhu(Nanchang University), Yuqi Wen(First Affiliated Hospital of Jiangxi Medical College), Hua Guo(San Francisco General Hospital), Bin Liao(Affiliated Hospital of Southwest Medical University), H. Ye(First Affiliated Hospital of Jiangxi Medical College), Feng Xiao(Nanchang University), Xuesong Shan(Nanchang University)
Cited by 3
Related Papers
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
|Blood|2004|787
Enrichment differentiation of human induced pluripotent stem cells into sinoatrial node-like cells by combined modulation of BMP, FGF, and RA signaling pathways
|Stem Cell Research & Therapy|2020|51
Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation
|Journal of Neuroinflammation|2023|35
Chemically defined and small molecules-based generation of sinoatrial node-like cells
|Stem Cell Research & Therapy|2022|22